Invention Grant
US08357688B2 Substituted imidazo[1,5-a]quinoxalin-4(5H)-ones as PDE9 inhibitors
有权
取代的咪唑并[1,5-a]喹喔啉-4（5H） - 酮作为PDE9抑制剂
![Substituted imidazo[1,5-a]quinoxalin-4(5H)-ones as PDE9 inhibitors](/docs/US/2013-01-22/US08357688B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted imidazo[1,5-a]quinoxalin-4(5H)-ones as PDE9 inhibitors
- Patent Title (中): 取代的咪唑并[1,5-a]喹喔啉-4（5H） - 酮作为PDE9抑制剂
-
Application No.: US13254368Application Date: 2010-03-04
-
Publication No.: US08357688B2Publication Date: 2013-01-22
- Inventor: Hiroyuki Kaizawa , Mari Sugita , Hidenori Azami , Ryushi Seo , Takaho Nomura , Satoshi Yamamoto , Hirofumi Yamamoto , Kazuyuki Tsuchiya , Hideki Kubota , Kazunori Kamijo
- Applicant: Hiroyuki Kaizawa , Mari Sugita , Hidenori Azami , Ryushi Seo , Takaho Nomura , Satoshi Yamamoto , Hirofumi Yamamoto , Kazuyuki Tsuchiya , Hideki Kubota , Kazunori Kamijo
- Applicant Address: JP Tokyo
- Assignee: Astellas Pharma Inc.
- Current Assignee: Astellas Pharma Inc.
- Current Assignee Address: JP Tokyo
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2009-052577 20090305
- International Application: PCT/JP2010/053586 WO 20100304
- International Announcement: WO2010/101230 WO 20100910
- Main IPC: A61K31/495
- IPC: A61K31/495
![Substituted imidazo[1,5-a]quinoxalin-4(5H)-ones as PDE9 inhibitors](/abs-image/US/2013/01/22/US08357688B2/abs.jpg.150x150.jpg)
Abstract:
Substituted imidazo[1,5-a]quinoxalin-4(5H)-ones are useful as PDE9 inhibitors.
Public/Granted literature
- US20110319385A1 QUINOXALINE COMPOUND Public/Granted day:2011-12-29
Information query
